MORRIS PLAINS, N.J., June 3, 2011 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that the Company will present at Jefferies 2011 Global Healthcare Conference at 3:30 p.m. on Thursday, June 9, 2011 in New York City. The presentation, which can be downloaded simultaneously at www.immunomedics.com/1aboutus/present.pdf, will provide a corporate overview.
